Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Piperazine Citrate Patent Expiration

Piperazine Citrate was first introduced by Glaxosmithkline in its drug Antepar on Approved Prior to Jan 1, 1982. Other drugs containing Piperazine Citrate are Multifuge, Bryrel. 8 different companies have introduced drugs containing Piperazine Citrate.


About Veterinary Piperazine Citrate

Piperazine Citrate is used in a drug marketed by 1 company: Sergeant’S Pet Care Products Llc.

Other drugs containing Piperazine Citrate are: Sergeants worm away for dogs , Sergeants worm away for cats .

Piperazine Citrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Piperazine Citrate Generic API Manufacturers

Several generic applications have been filed for Piperazine Citrate. The first generic version for Piperazine Citrate was by Luitpold Pharmaceuticals Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Solvay Pharmaceuticals and was approved on Approved Prior to Jan 1, 1982.

Given below is the list of companies who have filed for Piperazine Citrate generic, along with the locations of their manufacturing plants worldwide.